Astrup A, Greenway FL, Ling W, Pedicone L, Lachowicz J, Strader CD, Kwan R (2007). „Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects”. Obesity (Silver Spring, Md.). 15 (7): 1717—31. PMID17636090. doi:10.1038/oby.2007.205.
nih.gov
ncbi.nlm.nih.gov
Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A (1988). „Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity”. The Journal of Pharmacology and Experimental Therapeutics. 247 (3): 1093—102. PMID2905002.
Hou D, Schumacher D (2001). „The selection of a commercial route for the D1 antagonist Sch-39166”. Current Opinion in Drug Discovery & Development. 4 (6): 792—9. PMID11899619.
Astrup A, Greenway FL, Ling W, Pedicone L, Lachowicz J, Strader CD, Kwan R (2007). „Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects”. Obesity (Silver Spring, Md.). 15 (7): 1717—31. PMID17636090. doi:10.1038/oby.2007.205.
Hou, D; Schumacher, D (2001). „The selection of a commercial route for the D1 antagonist Sch-39166.”. Current opinion in drug discovery & development. 4 (6): 792—9. PMID11899619.